España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
CytoDyn
CYDY
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1980
0.00815
4.29%
At close: -
$0.2100
0.01
6.06%
After Hours: Jan 30, 9:16 AM EDT
Get Report
Comment
CytoDyn (CYDY) Forecast
News
Earnings
CytoDyn (CYDY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for CytoDyn (OTC:CYDY) Stock
CytoDyn Stock (OTC: CYDY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 09, 2024
CytoDyn Settles With Amarex Clinical Research...
Benzinga Newsdesk
Thursday, February 01, 2024
CytoDyn Announces Submission Of Clinical Prot...
Benzinga Newsdesk
Monday, January 29, 2024
CytoDyn Appoints Jacob Lalezari As CEO, Effec...
Benzinga Newsdesk
Tuesday, January 17, 2023
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
Jad Malaeb
-
Sponsored
Tuesday, December 13, 2022
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
Jad Malaeb
-
Sponsored
Thursday, October 27, 2022
Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
Jad Malaeb
-
Sponsored
Tuesday, August 16, 2022
OTC Markets' Most Active Securities Sees A Shake-up In July
Jad Malaeb
-
Sponsored
Friday, August 05, 2022
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
Chris Katje
Monday, July 18, 2022
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
Jad Malaeb
-
Sponsored
Thursday, March 31, 2022
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Shanthi Rexaline
Monday, February 14, 2022
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
Jad Malaeb
-
Sponsored
Monday, January 10, 2022
CytoDyn Highlights Research Paper 'Leronlimab (PRO 140) activity against 4-class drug resistant HIV-1 from Heavily Treatment Experienced Subjects' In ScienceDirect
Bill Haddad
Wednesday, December 29, 2021
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
Dana Salzarulo
-
Sponsored
Friday, November 05, 2021
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
Dana Salzarulo
-
Sponsored
Thursday, October 28, 2021
Is Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral?
Dana Salzarulo
-
Sponsored
Tuesday, October 12, 2021
These OTC Markets Securities had the Most Trading Activity in September
Austin Willson
-
Sponsored
Thursday, October 07, 2021
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Shanthi Rexaline
Friday, September 10, 2021
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Shanthi Rexaline
Wednesday, July 28, 2021
OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
Michael O'Connor
-
Sponsored
Tuesday, May 18, 2021
CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
Vandana Singh
CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment
Vandana Singh
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Shanthi Rexaline
Wednesday, May 12, 2021
These OTC Securities Had the Most Trading Activity in April
Sean Sechler
-
Sponsored
Thursday, April 08, 2021
Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
Shanthi Rexaline
Saturday, March 20, 2021
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
Shanthi Rexaline
Wednesday, March 17, 2021
Traders Demonstrate Enthusiasm For Emerging Sectors In February
Jaycee Tenn
Thursday, February 11, 2021
Traders Are Furiously Trading Companies In Emerging Industries
Jaycee Tenn
Monday, January 25, 2021
The Most Actively Traded Securities On OTC Markets In 2020 Included Cannabis, Crypto, And Multinationals
Spencer Israel
Tuesday, October 27, 2020
Traders Have Rotated Into Big Multinational Companies On OTC Markets
Spencer Israel
Tuesday, October 20, 2020
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
Shanthi Rexaline
Wednesday, August 26, 2020
Senior Administration Official Says CytoDyn I...
Benzinga Newsdesk
Monday, August 17, 2020
These Were The Hottest Companies On OTC Markets In July
Spencer Israel
Friday, August 07, 2020
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
Shanthi Rexaline
Monday, July 27, 2020
CytoDyn to Hold Conference Call on July 30 to Provide Updates on its Two COVID-19 Trials
Luke J Jacobi
Friday, July 24, 2020
Trading Activity In Emerging Names Increased On OTC Markets In June
Spencer Israel
Thursday, July 16, 2020
The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO
Shanthi Rexaline
Wednesday, July 15, 2020
CytoDyn Reports Filing Of application For Nas...
Benzinga Newsdesk
Monday, July 06, 2020
HC Wainwright & Co. Downgrades CytoDyn to Neu...
Benzinga Newsdesk
Tuesday, June 16, 2020
Traders Had Cannabis And Transportation Companies On OTC Markets In Focus During May
Spencer Israel
Thursday, May 21, 2020
These Were The Most Active Securities On OTC Markets In April
Spencer Israel
Tuesday, May 05, 2020
'CytoDyn CEO made $12M from his stock sale, a...
Benzinga Newsdesk
Tuesday, April 28, 2020
HC Wainwright & Co. Reiterates Buy on CytoDyn...
Benzinga Newsdesk
Monday, April 20, 2020
How The COVID-19 Pandemic Could End
Tyree Gorges
Thursday, April 16, 2020
The Spread of COVID-19 Has Caused Massive Volume Spikes In Securities On OTC Markets
Spencer Israel
Friday, April 03, 2020
H.C. Wainwright Reiterates Buy on CytoDyn, Ra...
Benzinga Newsdesk
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Monday, March 09, 2020
Coronavirus Fears Spark The Heaviest Trading Month In Over A Year On OTC Markets
Spencer Israel
Monday, February 24, 2020
Dollar Volume In GBTC More Than Doubled In January, As Coronavirus Fears Spurred A Crypto Rally
Spencer Israel
Thursday, January 30, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Wednesday, January 29, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Show More
